Breaking News Instant updates and real-time market news.

JBAXY

Julius Baer

$12.55 /

-0.21 (-1.65%)

04:32
12/06/21
12/06
04:32
12/06/21
04:32

Julius Baer upgraded to Buy from Neutral at UBS

UBS analyst Daniele Brupbacher upgraded Julius Baer to Buy from Neutral with a price target of CHF 71, up from CHF 63.

OTHER BREAKING NEWS FROM THE FLY

Options
Apple call buyer realizes 8% same-day gains » 08:00
06/27/22
06/27
08:00
06/27/22
08:00
AAPL

Apple

$141.87 /

+3.61 (+2.61%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$141.87 /

+3.61 (+2.61%)

AAPL Apple
$141.87 /

+3.61 (+2.61%)

07:05 Today Bernstein
Apple TV+ may have 20M-40M paying subscribers, says Bernstein
06/23/22 Bernstein
Bernstein worries Apple EPS estimates for 2023 may be too high
06/22/22 BofA
Apple App Store growth up 6% in fiscal Q3-to-date, says BofA
06/21/22 UBS
Apple iPhone shipments in China post 'strong rebound', says UBS
AAPL Apple
$141.87 /

+3.61 (+2.61%)

AAPL Apple
$141.87 /

+3.61 (+2.61%)

AAPL Apple
$141.87 /

+3.61 (+2.61%)

AAPL Apple
$141.87 /

+3.61 (+2.61%)

Hot Stocks
Stealth BioTherapeutics Corporation (ADS) trading resumes  08:00
06/27/22
06/27
08:00
06/27/22
08:00
MITO

Stealth Biotherapeutics

/

+

 
ShowHide Related Items >><<
MITO Stealth Biotherapeutics
/

+

MITO Stealth Biotherapeutics
/

+

05/23/22 H.C. Wainwright
Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright
07/01/21 Maxim
Stealth Biotherapeutics initiated with a Buy at Maxim
07/01/21 Maxim
Stealth Biotherapeutics initiated with a Buy at Maxim
MITO Stealth Biotherapeutics
/

+

Recommendations
UDR price target lowered to $48 from $60 at Mizuho » 07:59
06/27/22
06/27
07:59
06/27/22
07:59
UDR

UDR

$46.14 /

+0.435 (+0.95%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UDR UDR
$46.14 /

+0.435 (+0.95%)

UDR UDR
$46.14 /

+0.435 (+0.95%)

06/24/22 Truist
UDR price target lowered to $50 from $53 at Truist
06/22/22 Credit Suisse
UDR initiated with an Outperform at Credit Suisse
05/24/22 Truist
UDR price target lowered to $53 from $61 at Truist
05/19/22 Scotiabank
UDR price target lowered to $58 from $60 at Scotiabank
UDR UDR
$46.14 /

+0.435 (+0.95%)

  • 30
    Mar
Recommendations
MAA price target lowered to $178 from $221 at Mizuho » 07:59
06/27/22
06/27
07:59
06/27/22
07:59
MAA

MAA

$172.59 /

+2.33 (+1.37%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAA MAA
$172.59 /

+2.33 (+1.37%)

MAA MAA
$172.59 /

+2.33 (+1.37%)

06/24/22 Truist
MAA price target lowered to $188 from $205 at Truist
06/22/22 Credit Suisse
MAA initiated with an Outperform at Credit Suisse
05/24/22 Truist
MAA price target lowered to $205 from $220 at Truist
05/19/22 Scotiabank
MAA price target lowered to $226 from $231 at Scotiabank
MAA MAA
$172.59 /

+2.33 (+1.37%)

  • 03
    Aug
Hot Stocks
Imperial Oil receives acceptance from TSX to purchase up to 5% of shares » 07:59
06/27/22
06/27
07:59
06/27/22
07:59
IMO

Imperial Oil

$46.82 /

+2 (+4.46%)

, XOM

Exxon Mobil

$86.90 /

+1.69 (+1.98%)

Imperial Oil (IMO)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMO Imperial Oil
$46.82 /

+2 (+4.46%)

XOM Exxon Mobil
$86.90 /

+1.69 (+1.98%)

IMO Imperial Oil
$46.82 /

+2 (+4.46%)

06/16/22 National Bank
Imperial Oil price target raised to C$93 from C$80 at National Bank
06/16/22 RBC Capital
Imperial Oil price target raised to C$78 from C$66 at RBC Capital
06/08/22 Scotiabank
Imperial Oil price target raised to C$80 from C$72 at Scotiabank
05/12/22 RBC Capital
Imperial Oil price target raised to C$66 from C$65 at RBC Capital
XOM Exxon Mobil
$86.90 /

+1.69 (+1.98%)

06/21/22 Credit Suisse
Exxon Mobil upgraded to Outperform from Neutral at Credit Suisse
06/07/22 Evercore ISI
Evercore upgrades Exxon Mobil, sees 'achievable' path to doubling earnings
06/07/22 Credit Suisse
Exxon Mobil price target raised to $115 from $102 at Credit Suisse
06/07/22 Evercore ISI
Exxon Mobil upgraded to Outperform from In Line at Evercore ISI
IMO Imperial Oil
$46.82 /

+2 (+4.46%)

XOM Exxon Mobil
$86.90 /

+1.69 (+1.98%)

XOM Exxon Mobil
$86.90 /

+1.69 (+1.98%)

XOM Exxon Mobil
$86.90 /

+1.69 (+1.98%)

XOM Exxon Mobil
$86.90 /

+1.69 (+1.98%)

Recommendations
Essex Property Trust price target lowered to $273 from $342 at Mizuho » 07:59
06/27/22
06/27
07:59
06/27/22
07:59
ESS

Essex Property Trust

$261.65 /

+2.06 (+0.79%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESS Essex Property Trust
$261.65 /

+2.06 (+0.79%)

ESS Essex Property Trust
$261.65 /

+2.06 (+0.79%)

06:04 Today Piper Sandler
Essex Property Trust price target lowered to $340 from $400 at Piper Sandler
06/24/22 Truist
Essex Property Trust price target lowered to $299 from $323 at Truist
06/22/22 Credit Suisse
Essex Property Trust initiated with an Underperform at Credit Suisse
06/09/22 Stifel
Essex Property Trust price target lowered to $352 from $390 at Stifel
ESS Essex Property Trust
$261.65 /

+2.06 (+0.79%)

ESS Essex Property Trust
$261.65 /

+2.06 (+0.79%)

Recommendations
Equity Residential price target lowered to $79 from $84 at Mizuho » 07:59
06/27/22
06/27
07:59
06/27/22
07:59
EQR

Equity Residential

$71.82 /

-0.225 (-0.31%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EQR Equity Residential
$71.82 /

-0.225 (-0.31%)

06/24/22 Truist
Equity Residential price target lowered to $79 from $85 at Truist
06/22/22 Credit Suisse
Equity Residential initiated with an Outperform at Credit Suisse
06/22/22 RBC Capital
RBC Capital upgrades Equity Residential to Outperform on coastal exposure
06/22/22 RBC Capital
Equity Residential upgraded to Outperform from Sector Perform at RBC Capital
EQR Equity Residential
$71.82 /

-0.225 (-0.31%)

Recommendations
Camden Property price target lowered to $142 from $170 at Mizuho » 07:58
06/27/22
06/27
07:58
06/27/22
07:58
CPT

Camden Property

$135.13 /

+0.53 (+0.39%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CPT Camden Property
$135.13 /

+0.53 (+0.39%)

CPT Camden Property
$135.13 /

+0.53 (+0.39%)

06/24/22 Truist
Camden Property price target lowered to $149 from $160 at Truist
06/24/22 Baird
Camden Property price target lowered to $153 from $175 at Baird
05/25/22 Truist
Camden Property price target lowered to $160 from $186 at Truist
05/19/22 Scotiabank
Camden Property price target lowered to $171 from $179 at Scotiabank
CPT Camden Property
$135.13 /

+0.53 (+0.39%)

  • 08
    Apr
Recommendations
AvalonBay price target lowered to $212 from $260 at Mizuho » 07:58
06/27/22
06/27
07:58
06/27/22
07:58
AVB

AvalonBay

$195.14 /

-1.415 (-0.72%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVB AvalonBay
$195.14 /

-1.415 (-0.72%)

AVB AvalonBay
$195.14 /

-1.415 (-0.72%)

06/24/22 Truist
AvalonBay price target lowered to $224 from $263 at Truist
06/22/22 Credit Suisse
AvalonBay initiated with a Neutral at Credit Suisse
05/19/22 Scotiabank
AvalonBay price target lowered to $238 from $262 at Scotiabank
05/10/22 Barclays
AvalonBay price target lowered to $229 from $263 at Barclays
AVB AvalonBay
$195.14 /

-1.415 (-0.72%)

  • 07
    Apr
AVB AvalonBay
$195.14 /

-1.415 (-0.72%)

Recommendations
Apartment Income REIT price target lowered to $45 from $59 at Mizuho » 07:58
06/27/22
06/27
07:58
06/27/22
07:58
AIRC

Apartment Income REIT

$41.36 /

+0.02 (+0.05%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIRC Apartment Income REIT
$41.36 /

+0.02 (+0.05%)

AIRC Apartment Income REIT
$41.36 /

+0.02 (+0.05%)

06/24/22 Truist
Apartment Income REIT price target lowered to $45 from $49 at Truist
05/25/22 Truist
Apartment Income REIT price target lowered to $49 from $58 at Truist
05/19/22 Scotiabank
Apartment Income REIT price target lowered to $53 from $56 at Scotiabank
05/09/22 BTIG
Apartment Income REIT initiated with a Neutral at BTIG
AIRC Apartment Income REIT
$41.36 /

+0.02 (+0.05%)

Hot Stocks
Trump Media issues statement on Digital World Acquisition Corp. SEC filing » 07:55
06/27/22
06/27
07:55
06/27/22
07:55
DWAC

Digital World Acquisition

$27.81 /

-0.06 (-0.22%)

Trump Media &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

Recommendations
Amedisys' Contessa finalizing '9-figure revenue contract,' says Jefferies » 07:51
06/27/22
06/27
07:51
06/27/22
07:51
AMED

Amedisys

$115.40 /

+0.11 (+0.10%)

After having hosted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMED Amedisys
$115.40 /

+0.11 (+0.10%)

AMED Amedisys
$115.40 /

+0.11 (+0.10%)

06/22/22 Benchmark
Benchmark doesn't expect proposed Medicare home health cut to make final rule
06/21/22 BofA
Amedisys cut to Underperform at BofA after CMS proposal on home health rates
06/21/22 BofA
Amedisys downgraded to Underperform from Neutral at BofA
06/21/22 Deutsche Bank
Amedisys price target lowered to $175 from $210 at Deutsche Bank
AMED Amedisys
$115.40 /

+0.11 (+0.10%)

Hot Stocks
Cronos Group announces partnership with Geocann » 07:49
06/27/22
06/27
07:49
06/27/22
07:49
CRON

Cronos Group

$3.11 /

+0.155 (+5.25%)

Cronos Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

Hot Stocks
Freyr announces Minister of Trade, Industry launched Norwegian battery strategy » 07:45
06/27/22
06/27
07:45
06/27/22
07:45
FREY

Freyr Battery

$6.93 /

-0.005 (-0.07%)

FREYR Battery welcomes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

06/20/22 Goldman Sachs
Freyr Battery initiated with a Neutral at Goldman Sachs
03/17/22 US Capital Advisors
Freyr Battery initiated with a Buy at US Capital Advisors
01/26/22 Clarksons Platou
Freyr Battery initiated with a Buy at Clarksons Platou
01/04/22 Morgan Stanley
Ferrari replacing GM as Morgan Stanley's new 'Top Pick' in U.S. autos
FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

Conference/Events
Relay Therapeutics to hold virtual event » 07:45
06/27/22
06/27
07:45
06/27/22
07:45
RLAY

Relay Therapeutics

$20.87 /

+1.87 (+9.84%)

Virtual Investor and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLAY Relay Therapeutics
$20.87 /

+1.87 (+9.84%)

RLAY Relay Therapeutics
$20.87 /

+1.87 (+9.84%)

06/06/22 Jefferies
Relay Therapeutics initiated with an Underperform at Jefferies
05/10/22 H.C. Wainwright
Relay Therapeutics price target lowered to $47 from $54 at H.C. Wainwright
05/09/22 JMP Securities
Relay Therapeutics price target lowered to $35 from $50 at JMP Securities
02/01/22 Berenberg
Relay Therapeutics initiated with a Buy at Berenberg
RLAY Relay Therapeutics
$20.87 /

+1.87 (+9.84%)

  • 13
    Oct
Recommendations
Altria Group price target lowered to $45 from $56 at Cowen » 07:43
06/27/22
06/27
07:43
06/27/22
07:43
MO

Altria Group

$43.41 /

+0.905 (+2.13%)

Cowen analyst Vivien Azer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MO Altria Group
$43.41 /

+0.905 (+2.13%)

MO Altria Group
$43.41 /

+0.905 (+2.13%)

06/24/22 Morgan Stanley
Altria Group upgraded to Equal Weight from Underweight at Morgan Stanley
06/22/22 Goldman Sachs
Altria selloff overdone on potential FDA action on JUUL, says Goldman Sachs
06/22/22 Stifel
Potential ban of JUUL vapor products 'clear negative' for Altria, says Stifel
06/22/22 Jefferies
FDA lowered nicotine rule likely to take many years to implement, says Jefferies
MO Altria Group
$43.41 /

+0.905 (+2.13%)

MO Altria Group
$43.41 /

+0.905 (+2.13%)

MO Altria Group
$43.41 /

+0.905 (+2.13%)

MO Altria Group
$43.41 /

+0.905 (+2.13%)

Recommendations
Rockwell Automation price target lowered to $260 from $277 at Morgan Stanley » 07:42
06/27/22
06/27
07:42
06/27/22
07:42
ROK

Rockwell Automation

$201.07 /

+3.735 (+1.89%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

05/24/22 Barclays
Rockwell Automation price target lowered to $200 from $220 at Barclays
05/10/22 HSBC
Rockwell Automation price target lowered to $240 from $293 at HSBC
05/05/22 JPMorgan
Rockwell Automation price target lowered to $200 from $220 at JPMorgan
05/04/22 Oppenheimer
Rockwell Automation price target lowered to $290 from $360 at Oppenheimer
ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

Recommendations
Roche price target lowered to $48 from $58 at Cowen » 07:41
06/27/22
06/27
07:41
06/27/22
07:41
RHHBY

Roche

$41.64 /

+1.63 (+4.07%)

Cowen analyst Steve Scala…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$41.64 /

+1.63 (+4.07%)

RHHBY Roche
$41.64 /

+1.63 (+4.07%)

06/02/22 Piper Sandler
Piper ups Repare Therapeutics target after 'great deal' with Roche
05/19/22 Credit Suisse
Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
05/12/22 Morgan Stanley
Roche price target lowered to CHF 370 from CHF 395 at Morgan Stanley
RHHBY Roche
$41.64 /

+1.63 (+4.07%)

RHHBY Roche
$41.64 /

+1.63 (+4.07%)

RHHBY Roche
$41.64 /

+1.63 (+4.07%)

Hot Stocks
Accenture to acquire XtremeEDA, terms not disclosed » 07:39
06/27/22
06/27
07:39
06/27/22
07:39
ACN

Accenture

$299.36 /

+13.3 (+4.65%)

Accenture "has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$299.36 /

+13.3 (+4.65%)

ACN Accenture
$299.36 /

+13.3 (+4.65%)

06/25/22 Barclays
Accenture price target lowered to $370 from $455 at Barclays
06/24/22 RBC Capital
Accenture price target lowered to $357 from $435 at RBC Capital
06/24/22 Cowen
Accenture price target lowered to $325 from $330 at Cowen
06/24/22 Baird
Accenture price target lowered to $310 from $340 at Baird
ACN Accenture
$299.36 /

+13.3 (+4.65%)

ACN Accenture
$299.36 /

+13.3 (+4.65%)

ACN Accenture
$299.36 /

+13.3 (+4.65%)

Recommendations
Merck price target raised to $102 from $95 at Cowen » 07:39
06/27/22
06/27
07:39
06/27/22
07:39
MRK

Merck

$93.22 /

+1.14 (+1.24%)

, SGEN

Seagen

$179.14 /

+5.07 (+2.91%)

Cowen analyst Boris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$93.22 /

+1.14 (+1.24%)

SGEN Seagen
$179.14 /

+5.07 (+2.91%)

MRK Merck
$93.22 /

+1.14 (+1.24%)

06/24/22 Mizuho
Merck deal would add 'novel and validated technology,' says Mizuho
06/21/22 Oppenheimer
Seagen price target raised to $208 from $160 at Oppenheimer
04/12/22 Barclays
Merck price target raised to $97 from $94 at Barclays
04/11/22 H.C. Wainwright
Rubius Therapeutics price target lowered to $15 from $40 at H.C. Wainwright
SGEN Seagen
$179.14 /

+5.07 (+2.91%)

06/24/22 Mizuho
Merck deal would add 'novel and validated technology,' says Mizuho
06/23/22 BMO Capital
Seagen initiated with a Market Perform at BMO Capital
06/21/22 Morgan Stanley
Seagen named 'Catalyst Driven Idea' at Morgan Stanley
06/21/22 Oppenheimer
Seagen price target raised to $208 from $160 at Oppenheimer
MRK Merck
$93.22 /

+1.14 (+1.24%)

SGEN Seagen
$179.14 /

+5.07 (+2.91%)

MRK Merck
$93.22 /

+1.14 (+1.24%)

SGEN Seagen
$179.14 /

+5.07 (+2.91%)

MRK Merck
$93.22 /

+1.14 (+1.24%)

SGEN Seagen
$179.14 /

+5.07 (+2.91%)

MRK Merck
$93.22 /

+1.14 (+1.24%)

Hot Stocks
Clover's COVID vaccine candidate shows 'strong' neutralization against variant » 07:39
06/27/22
06/27
07:39
06/27/22
07:39
DVAX

Dynavax

$12.34 /

+0.07 (+0.57%)

China's Clover…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

01/05/22 Goldman Sachs
Goldman reinstates Dynavax at Buy, sees value creation from COVID platform
12/29/21 H.C. Wainwright
Dynavax price target raised to $28 from $23 at H.C. Wainwright
08/31/21 H.C. Wainwright
Dynavax price target raised to $23 from $20 at H.C. Wainwright
08/05/21 Goldman Sachs
Dynavax initiated with a Buy at Goldman Sachs
DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

Hot Stocks
TG Therapeutics presents exploratory analyses from ublituximab in MS trial » 07:38
06/27/22
06/27
07:38
06/27/22
07:38
TGTX

TG Therapeutics

$4.39 /

-0.235 (-5.08%)

TG Therapeutics …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

06/13/22 B. Riley
TG Therapeutics price target lowered to $17 from $23 at B. Riley
05/20/22 BofA
BofA starts TG Therapeutics at Underperform, sees difficult commercial setup
05/20/22 BofA
TG Therapeutics initiated with an Underperform at BofA
04/19/22 B. Riley
TG Therapeutics application withdrawal 'clearing event,' says B. Riley
TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

Recommendations
Televisa price target lowered to $13 from $15.50 at JPMorgan » 07:38
06/27/22
06/27
07:38
06/27/22
07:38
TV

Televisa

$8.71 /

+0.34 (+4.06%)

JPMorgan analyst Marcelo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TV Televisa
$8.71 /

+0.34 (+4.06%)

06/01/22 Goldman Sachs
Televisa reinstated with a Neutral at Goldman Sachs
03/23/22 Barclays
Televisa upgraded to Equal Weight from Underweight at Barclays
03/18/22 JPMorgan
America Movil downgraded to Neutral from Overweight at JPMorgan
03/18/22 JPMorgan
Televisa resumed with Overweight from Neutral at JPMorgan
TV Televisa
$8.71 /

+0.34 (+4.06%)

Recommendations
Copa Holdings price target lowered to $76 from $90 at JPMorgan » 07:38
06/27/22
06/27
07:38
06/27/22
07:38
CPA

Copa Holdings

$63.84 /

+2.61 (+4.26%)

JPMorgan analyst Fernando…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPA Copa Holdings
$63.84 /

+2.61 (+4.26%)

CPA Copa Holdings
$63.84 /

+2.61 (+4.26%)

05/13/22 Barclays
Barclays double upgrades Copa Holdings on improving operations
05/13/22 Barclays
Copa Holdings upgraded to Overweight from Underweight at Barclays
04/13/22 Raymond James
Copa Holdings price target lowered to $110 from $115 at Raymond James
02/23/22 Barclays
Copa Holdings price target raised to $96 from $82 at Barclays
CPA Copa Holdings
$63.84 /

+2.61 (+4.26%)

Hot Stocks
DocGo to be added to Russell 2000 Index » 07:37
06/27/22
06/27
07:37
06/27/22
07:37
DCGO

DocGo

$7.11 /

-0.39 (-5.20%)

DocGo announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DCGO DocGo
$7.11 /

-0.39 (-5.20%)

DCGO DocGo
$7.11 /

-0.39 (-5.20%)

05/11/22 Canaccord
DocGo price target lowered to $10 from $13 at Canaccord
04/19/22 Deutsche Bank
DocGo initiated with a Buy at Deutsche Bank
01/19/22 Stifel
DocGo initiated with a Buy at Stifel
01/04/22 Northland
DocGo named a top pick for 2022 at Northland
DCGO DocGo
$7.11 /

-0.39 (-5.20%)

DCGO DocGo
$7.11 /

-0.39 (-5.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.